Microba Life Sciences Ltd News

Microba Life Sciences Ltd: Trading Update

ASXNov 29 06:04 · Announcements

Microba Life Sciences Ltd: Microba receives $6 million R&D Tax Incentive Refund

ASXNov 18 06:08 · Announcements

Microba Life Sciences Ltd: Annual Report to Shareholders

ASXOct 28 12:50 · Announcements

Microba Life Sciences Ltd: Details of Q1 FY25 Quarterly Report, Appendix 4C & Webinar

ASXOct 23 06:24 · Announcements

Clinical Microbiomics A/S Announces New Deal With Microba Life Sciences Ltd's and Prepares to Launch New Company Brand in November 2024

PR NewswireOct 15 21:35

Analysts Expect Breakeven For Microba Life Sciences Limited (ASX:MAP) Before Long

Yahoo FinanceOct 11 07:52

Microba Life Sciences Agrees to Transfer Research Services Business to Clinical Microbiomics

MT NewswiresOct 11 06:56

Microba Life Sciences Ltd: 2024 Annual Report & Appendix 4E

Aug 29 07:10 · Announcements

Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3%

MT NewswiresJun 28 11:01

Microba's Revenue Climbs 297% in Fiscal Q3

MT NewswiresApr 24 05:40

Microba Life Sciences Secures AU$6 Million Tax Rebate for Fiscal Year 2023; Shares Fall 5%

MT NewswiresApr 10 09:43

Microba's Domestic Revenues to Get Boost From Sonic Partnership -- Market Talk

WSJMar 19 06:57

Australian Shares Track Gains of Wall Street Peers as Market Shrugs Off US Inflation Data

MT NewswiresMar 13 13:51

Microba Life Sciences Rise 9% Following Launch of MetaPanel Test With Sonic Healthcare

MT NewswiresMar 13 09:30

Miroba Life Sciences Price Target Cut 20% to A$0.35/Share by Bell Potter

Dow JonesMar 1 05:22

Microbia Life Sciences Offers Compelling Long-Term Opportunity -- Market Talk

WSJFeb 7 08:58

Microba Life Sciences Started With A$0.35/Share Target Price by Morgans>MAP.AU

Dow JonesFeb 7 07:41

Microba Life Sciences Validates Safety, Tolerability of Inflammatory Bowel Disease Therapy in Phase One Trial

MT NewswiresDec 7, 2023 11:48

Microba Life Sciences Completes Acquisition of UK Microbiome Testing Company; Shares Slide 5%

MT NewswiresDec 6, 2023 12:56

Microba Life Sciences Signs Research Agreement With IFF Subsidiary to Develop Allergy Treatments

MT NewswiresDec 4, 2023 11:21